Variable | Total n = 51 | TICI 0-2 A n = 9 | TICI 2B-3 n = 42 | p |
---|---|---|---|---|
Sex | Â | Â | Â | 1 |
  Male | 32 | 6 (66.6 %) | 26 (61.9 %) |  |
  Female | 19 | 3 (33.3 %) | 16 (38.1 %) |  |
Age (years) | 68.3 (61.4–76) | 72 (63–69.5) | 67.9 (58.4–77.2) | 0.692 |
Diabetes | Â | Â | Â | 0.436 |
  Yes | 16 | 4 (44.4 %) | 12 (28.6 %) |  |
  No | 35 | 5 (55.5 %) | 30 (71.4 %) |  |
Hyperlipidemia | Â | Â | Â | 1 |
  Yes | 24 | 4 (44.4 %) | 20 (47.6 %) |  |
  No | 27 | 5 (55.5 %) | 22 (52.4 %) |  |
Hypertension | Â | Â | Â | 0.709 |
  Yes | 36 | 7 (77.7 %) | 29 (69.0 %) |  |
  No | 15 | 2 (22.2 %) | 13 (31.0 %) |  |
Atrial fibrilation | Â | Â | Â | 0.095 |
  Yes | 7 | 3 (33.3 %) | 4 (9.5 %) |  |
  No | 44 | 6 (66.6 %) | 38 (90.5 %) |  |
ASPECTS | Â | Â | Â | 0.718 |
  9–10 | 27 | 4 (44.4 %) | 23 (54.8 %) |  |
  8 or less | 24 | 5 (55.5 %) | 19 (45.2 %) |  |
Occlusion type | Â | Â | Â | 0.417 |
  Atherosclerotic | 38 | 8 (88.8 %) | 30 (71.4 %) |  |
  Dissection | 13 | 1 (11.1 %) | 12 (28.6 %) |  |
Occlusion location | Â | Â | Â | 1 |
  Tandem | 42 | 8 (88.8 %) | 34 (81.0 %) |  |
  Extracranial | 9 | 1 (11.1 %) | 8 (19.0 %) |  |
Preprocedural therapy | Â | Â | Â | 0.720 |
  Yes | 21 | 3 (33.3 %) | 18 (42.9 %) |  |
  No | 30 | 6 (66.6 %) | 24 (57.1 %) |  |
Intraprocedural therapy | Â | Â | Â | 0.134 |
  Yes | 18 | 1 (11.1 %) | 17 (40.5 %) |  |
  No | 33 | 8 (88.8 %) | 25 (59.5 %) |  |
Postprocedural therapy | Â | Â | Â | 0.001 |
  ASA | 15 | 3 (33.3 %) | 12 (28.6 %) |  |
  ASA + Clopidogrel | 33 | 3 (33.3 %) | 30 (71.4 %) |  |
  Heparin/none | 3 | 3 (33.3 %) | 0 (0 %) |  |
Hemorrhagic transformation | Â | Â | Â | 0.009 |
  Yes | 10 | 5 (55.5 %) | 5 (11.9 %) |  |
  No | 41 | 4 (44.4 %) | 37 (88.1 %) |  |
  Procedure time (minutes) | 69 (46–90) | 70 (55–90) | 68.5 (45.5–90) | 0.683 |
Extracranial technique | Â | Â | Â | 0.081 |
  PTA | 18 | 4 (44.4 %) | 14 (33.3 %) |  |
  Stent | 6 | 1 (11.1 %) | 5 (11.9 %) |  |
  PTA + Stent | 15 | 0 (0 %) | 15 (35.7 %) |  |
  None/other | 12 | 4 (44.4 %) | 8 (19.0 %) |  |
Intracranial technique | Â | Â | Â | 0.791 |
  ADAPT | 28 | 5 (55.5 %) | 23 (54.8 %) |  |
  Solumbra | 11 | 0 (0 %) | 2 (4.8 %) |  |
  Retriever | 2 | 3 (33.3 %) | 8 (19.0 %) |  |
  None | 10 | 1 (11.1 %) | 9 (21.4 %) |  |
Stent | Â | Â | Â | 0.064 |
  Yes | 21 | 1 (11.1 %) | 20 (47.6 %) |  |
  No | 30 | 8 (88.8 %) | 22 (52.4 %) |  |